170 related articles for article (PubMed ID: 33957930)
41. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
42. Primary sclerosing cholangitis: outcome of patients undergoing restorative proctocolecetomy for ulcerative colitis.
Lepistö A; Kivistö S; Kivisaari L; Arola J; Järvinen HJ
Int J Colorectal Dis; 2009 Oct; 24(10):1169-74. PubMed ID: 19636573
[TBL] [Abstract][Full Text] [Related]
43. Increased intercellular adhesion molecule-1 serum concentration in cholestasis.
Polzien F; Ramadori G
J Hepatol; 1996 Dec; 25(6):877-86. PubMed ID: 9007716
[TBL] [Abstract][Full Text] [Related]
44. Chronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis.
Fejfar T; Vaňásek T; Hůlek P
Vnitr Lek; 2020; 66(5):287-300. PubMed ID: 32942866
[TBL] [Abstract][Full Text] [Related]
45. Inflammation But Not Biliary Obstruction Is Associated With Carbohydrate Antigen 19-9 Levels in Patients With Primary Sclerosing Cholangitis.
Wannhoff A; Rupp C; Friedrich K; Brune M; Knierim J; Flechtenmacher C; Sauer P; Stremmel W; Hov JR; Schirmacher P; Weiss KH; Gotthardt DN
Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2372-9. PubMed ID: 26192140
[TBL] [Abstract][Full Text] [Related]
46. Primary sclerosing cholangitis: evaluation with MR cholangiography-a case-control study.
Fulcher AS; Turner MA; Franklin KJ; Shiffman ML; Sterling RK; Luketic VA; Sanyal AJ
Radiology; 2000 Apr; 215(1):71-80. PubMed ID: 10751470
[TBL] [Abstract][Full Text] [Related]
47. Association between serum IgG level and clinical course in primary sclerosing cholangitis.
Hippchen T; Sauer P; Göppert B; Schirmacher P; Gotthardt DN; Weiss KH; Stremmel W; Rupp C
BMC Gastroenterol; 2019 Aug; 19(1):153. PubMed ID: 31455255
[TBL] [Abstract][Full Text] [Related]
48. Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value.
de Vries EM; Wang J; Leeflang MM; Boonstra K; Weersma RK; Beuers UH; Geskus RB; Ponsioen CY
Liver Int; 2016 Dec; 36(12):1867-1875. PubMed ID: 26945698
[TBL] [Abstract][Full Text] [Related]
49. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
[TBL] [Abstract][Full Text] [Related]
50. Accumulation of macrophages in primary sclerosing cholangitis.
Cameron RG; Blendis LM; Neuman MG
Clin Biochem; 2001 May; 34(3):195-201. PubMed ID: 11408017
[TBL] [Abstract][Full Text] [Related]
51. Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis.
Peiseler M; Reiners D; Pinnschmidt HO; Sebode M; Jung F; Hartl J; Zenouzi R; Ehlken H; Groth S; Schachschal G; Rösch T; Weiler-Normann C; Lohse AW; Schramm C
PLoS One; 2018; 13(8):e0202686. PubMed ID: 30125307
[TBL] [Abstract][Full Text] [Related]
52. Primary sclerosing cholangitis.
Rodriguez HJ; Bass NM
Semin Gastrointest Dis; 2003 Oct; 14(4):189-98. PubMed ID: 14719769
[TBL] [Abstract][Full Text] [Related]
53. The pathology of cholestasis.
Li MK; Crawford JM
Semin Liver Dis; 2004 Feb; 24(1):21-42. PubMed ID: 15085484
[TBL] [Abstract][Full Text] [Related]
54. Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience.
Lemoinne S; Pares A; Reig A; Ben Belkacem K; Kemgang Fankem AD; Gaouar F; Poupon R; Housset C; Corpechot C; Chazouillères O
Clin Res Hepatol Gastroenterol; 2018 Dec; 42(6):521-528. PubMed ID: 30100231
[TBL] [Abstract][Full Text] [Related]
55. Transient Elastography (FibroScan) Is Not Correlated With Liver Fibrosis but With Cholestasis in Patients With Long-Term Home Parenteral Nutrition.
Van Gossum A; Pironi L; Messing B; Moreno C; Colecchia A; D'Errico A; Demetter P; De Gos F; Cazals-Halem D; Joly F
JPEN J Parenter Enteral Nutr; 2015 Aug; 39(6):719-24. PubMed ID: 24913657
[TBL] [Abstract][Full Text] [Related]
56. Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis.
Saffioti F; Roccarina D; Vesterhus M; Hov JR; Rosenberg W; Pinzani M; Pereira SP; Boberg KM; Thorburn D
Eur J Clin Invest; 2019 May; 49(5):e13088. PubMed ID: 30762236
[TBL] [Abstract][Full Text] [Related]
57. Relationship between apoptosis, tumour necrosis factor, and cell proliferation in chronic cholestasis.
Floreani A; Guido M; Bortolami M; Della Zentil G; Venturi C; Pennelli N; Naccarato R
Dig Liver Dis; 2001 Oct; 33(7):570-5. PubMed ID: 11816546
[TBL] [Abstract][Full Text] [Related]
58. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
Stiehl A
Ann Med; 1994 Oct; 26(5):345-9. PubMed ID: 7826595
[TBL] [Abstract][Full Text] [Related]
59. [Chronic cholestatic disorders in the adult].
Chazouillères O
Pathol Biol (Paris); 1999 Nov; 47(9):974-82. PubMed ID: 10609278
[TBL] [Abstract][Full Text] [Related]
60. Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures.
Levy MJ; Baron TH; Clayton AC; Enders FB; Gostout CJ; Halling KC; Kipp BR; Petersen BT; Roberts LR; Rumalla A; Sebo TJ; Topazian MD; Wiersema MJ; Gores GJ
Am J Gastroenterol; 2008 May; 103(5):1263-73. PubMed ID: 18477350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
